Esbriet 801 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJEAL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,426
Award facts
- Contract value 100% obligated
- $3,425.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,425.95 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Esbriet 801 mg on August 28, 2025, with completion targeted by September 19, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside provisions and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement.
This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a global pharmaceutical support vehicle. Esbriet (pirfenidone) is a specialty pharmaceutical used in the treatment of idiopathic pulmonary fibrosis and represents the type of specialized medication within AmerisourceBergen's diverse portfolio of brand-name and generic drugs that support military healthcare programs and the Defense Health Agency. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its expansive IDC framework, positions it as a strategic pharmaceutical supplier for Department of Defense healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FJEAL?
SPE2DB25FJEAL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FJEAL worth?
The government has obligated $3,426 on SPE2DB25FJEAL.
Is contract SPE2DB25FJEAL an order under another contract?
Yes. SPE2DB25FJEAL is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DB25FJEAL competed?
The extent of competition for SPE2DB25FJEAL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award